The Effect of Training Based on the Transtheoretical Model on Pelvic Floor Muscle Strength

NCT07443423 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 64

Last updated 2026-03-02

No results posted yet for this study

Summary

The study was designed to evaluate the effect of training based on the transtheoretical model on pelvic floor muscle strength in women.

The study was designed as a randomized controlled single-blind experimental study with pre-test and post-test measurements and will be conducted with sexually active women aged 18 and over who meet the inclusion criteria and who applied to the Sevgi Family Health Center No. 13 in Gaziemir District, Izmir Province.

Conditions

  • Pelvic Floor Awareness

Interventions

OTHER

TRAINING BASED ON THE TRANSTEOROTİK MODEL

Women in the intervention group will receive awareness training on pelvic floor muscle exercises based on the transtheoretical model. This training includes a brochure and a seminar program prepared according to the transtheoretical model. A monthly exercise schedule will be provided to the women in this group to support them in performing pelvic floor muscle exercises.

OTHER

Not providing training

Once the data collection phase of the study is complete, women in the control group will also be given a detailed explanation of pelvic floor muscle exercises based on the transtheoretical model and awareness training, and will be provided with a brochure.

Sponsors & Collaborators

  • Aynur Erçek Karci

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-03-01
Primary Completion
2026-05-01
Completion
2026-08-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07443423 on ClinicalTrials.gov